Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KalVista Pharmaceuticals (KALV)

KalVista Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KALV
DateTimeSourceHeadlineSymbolCompany
21/05/202422:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
21/05/202422:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
21/05/202422:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
21/05/202422:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
21/05/202411:30Business WireKalVista Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:KALVKalVista Pharmaceuticals Inc
02/05/202411:30Business WireKalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALVKalVista Pharmaceuticals Inc
01/05/202411:30Business WireKalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal YearNASDAQ:KALVKalVista Pharmaceuticals Inc
22/04/202411:30Business WireKalVista Pharmaceuticals Appoints William C. Fairey to Board of DirectorsNASDAQ:KALVKalVista Pharmaceuticals Inc
03/04/202411:30Business WireKalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:KALVKalVista Pharmaceuticals Inc
02/04/202411:30Business WireKalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALVKalVista Pharmaceuticals Inc
18/03/202410:30Business WireKalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference AmericasNASDAQ:KALVKalVista Pharmaceuticals Inc
12/03/202410:30Business WireKalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for SebetralstatNASDAQ:KALVKalVista Pharmaceuticals Inc
11/03/202420:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALVKalVista Pharmaceuticals Inc
11/03/202420:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALVKalVista Pharmaceuticals Inc
11/03/202410:30Business WireKalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational UpdateNASDAQ:KALVKalVista Pharmaceuticals Inc
08/03/202421:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
08/03/202411:30Business WireKalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference AmericasNASDAQ:KALVKalVista Pharmaceuticals Inc
07/03/202411:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALVKalVista Pharmaceuticals Inc
07/03/202411:30Business WireKalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive OfficerNASDAQ:KALVKalVista Pharmaceuticals Inc
06/03/202411:30Business WireKalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma ConferenceNASDAQ:KALVKalVista Pharmaceuticals Inc
04/03/202411:30Business WireKalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALVKalVista Pharmaceuticals Inc
27/02/202411:30Business WireKalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual MeetingNASDAQ:KALVKalVista Pharmaceuticals Inc
26/02/202411:30Business WireKalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual MeetingNASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202418:22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202402:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202402:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202402:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202402:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
22/02/202402:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALVKalVista Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:KALV

Your Recent History

Delayed Upgrade Clock